During the past decade, Prisma Health Midlands conducted 10 clinical trials. In the 10-year time frame, 10 clinical trials started and 2 clinical trials were completed, i.e. on average, 20% percent of trials that started reached the finish line to date. In the past 5 years, 8 clinical trials started and 2 clinical trials were completed. i.e. 25% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Prisma Health Midlands" #1 sponsor was "Gilead Sciences" with 2 trials, followed by "Prisma Health-Midlands" with 2 trials sponsored, "Abbott Medical Devices" with 1 trials sponsored, "CSA Medical, Inc." with 1 trials sponsored and "IDeA States Pediatric Clinical Trials Network" with 1 trials sponsored. Other sponsors include -2 different institutions and companies that sponsored additional 8 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Prisma Health Midlands" #1 collaborator was "IQVIA Biotech" with 1 trials as a collaborator, "Medpace, Inc." with 1 trials as a collaborator, "National Institutes of Health (NIH)" with 1 trials as a collaborator, "University of Montana" with 1 trials as a collaborator and "University of Vermont Medical Center" with 1 trials as a collaborator. Other collaborators include -5 different institutions and companies that were collaborators in the rest 5 trials.

According to Clinical.Site data, the most researched conditions in "Prisma Health Midlands" are "COVID-19" (2 trials), "Heart Failure NYHA Class II" (2 trials), "Heart Failure NYHA Class III" (2 trials), "Achilles Tendon Surgery" (1 trials) and "Ankle Fractures" (1 trials). Many other conditions were trialed in "Prisma Health Midlands" in a lesser frequency.

Most popular intervention types in "Prisma Health Midlands" are "Drug" (5 trials), "Device" (4 trials) and "Other" (2 trials). Other intervention types were less common.

The name of intervention was led by "Remdesivir" (2 trials), "Standard of Care" (2 trials), "Acetominophen" (1 trials), "CardioMEMS™ HF System" (1 trials) and "Cyclobenzaprine" (1 trials). Other intervention names were less common.

The vast majority of trials in "Prisma Health Midlands" are 10 trials for "All" genders.

Currently, there are NaN active trials in "Prisma Health Midlands". undefined are not yet recruiting, 3 are recruiting, 3 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 3 completed trials in Prisma Health Midlands, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Prisma Health Midlands, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 3 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 5 trials that are defined as “Not Applicable".